Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2001-04-01
Metadata
Show full item recordCitation
J. Rheumatol. 2001, 28(4):728-34Abstract
OBJECTIVE: To determine whether low mannose binding lectin (MBL) is associated with poor prognosis in rheumatoid arthritis (RA) and whether patients with RA have increased frequency of MBL deficiency. METHODS: Patients with recent onset symmetric polyarthritis (< 1 year, median 3 mo) were recruited if they had not been treated longer than 2 weeks with disease modifying drugs. They were reevaluated after 6 months and their disease activity and progression were correlated with their MBL concentration, rheumatoid factor (RF) isotypes, and C-reactive protein (CRP). Sixty-three female patients with advanced RA were also analyzed. RESULTS: Sixty-five patients with early arthritis fulfilled American College of Rheumatology criteria for RA and 52 were followed for 6 months or longer. Low MBL was associated with raised RF, IgA RF in particular (p = 0.02). and also with a combined elevation of IgM and IgA RF (p = 0.035). Patients with low MBL (lowest 25th percentile) showed less improvement after 6 months of treatment than patients in the highest MBL quartile. This applied to the Thompson joint score (p = 0.03) and grip strength (p = 0.004). Low MBL was also significantly associated with radiological joint erosions at recruitment and at 6 month followup (p = 0.039); and the group with advanced RA also showed a significant association between low MBL concentration and radiological damage (p = 0.036). However. neither patient group had increased frequency of MBL deficiency compared to healthy controls. CONCLUSION: Low MBL predicts poor prognosis in patients with early RA.Description
To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldAdditional Links
http://jrheum.com/subscribers/01/04/728.htmlCollections
Related articles
- The influence of mannose binding lectin polymorphisms on disease outcome in early polyarthritis. TIRA Group.
- Authors: Jacobsen S, Madsen HO, Klarlund M, Jensen T, Skjødt H, Jensen KE, Svejgaard A, Garred P, TIRA Group.
- Issue date: 2001 May
- Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease.
- Authors: Machold KP, Stamm TA, Eberl GJ, Nell VK, Dunky A, Uffmann M, Smolen JS
- Issue date: 2002 Nov
- Mannan binding lectin in rheumatoid arthritis. A longitudinal study.
- Authors: Graudal NA, Homann C, Madsen HO, Svejgaard A, Jurik AG, Graudal HK, Garred P
- Issue date: 1998 Apr
- Serum IgA rheumatoid factor and pyridinoline in very early arthritis as predictors of erosion(s) at two years: a simple model of prediction from a conservatively treated community-based inception cohort.
- Authors: Le Loët X, Brazier M, Mejjad O, Boumier P, Daragon A, Gayet A, Pouplin S, Tron F, Zarnitsky C, Vittecoq O, Menard JF, Fardellone P
- Issue date: 2010 Dec